Novel treatment strategies for aggressive non-Hodgkin's lymphoma

被引:5
作者
Fayad, L [1 ]
Younes, A [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
关键词
Akt; aurora; BAFF; CD40; Hsp-90; HDAC; mTOR; PLK; TRAIL;
D O I
10.1517/14656566.7.6.733
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The World Health Organization has included different types of lymphoma under the aggressive category. In the US, diffuse large B-cell lymphoma is the most common aggressive lymphoma and accounts for > 30% of the 55,000 new cases diagnosed annually. Recent advances in the knowledge of the molecular biology have provided an increased understanding of the heterogeneity of non-Hodgkin's lymphoma. New treatments, especially those with the use of monoclonal antibodies, are improving both the survival and the response rate.
引用
收藏
页码:733 / 748
页数:16
相关论文
共 50 条
[21]   A phase I pharmacokinetic study of copanlisib in Chinese patients with relapsed indolent non-Hodgkin lymphoma [J].
Liu, Weiping ;
Ping, Lingyan ;
Xie, Yan ;
Sun, Yingli ;
Du, Tingting ;
Niu, Yi ;
Cisternas, Galia ;
Huang, Funan ;
Garcia-Vargas, Jose ;
Childs, Barrett H. ;
Mehra, Aruna ;
Reschke, Susanne ;
Wang, Xiaopei ;
Song, Yuqin ;
Zhu, Jun .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (06) :825-831
[22]   Association between B Cell Growth Factors and Primary Sjogren's Syndrome-Related Autoantibodies in Patients with Non-Hodgkin's Lymphoma [J].
Xian, Zhenhua ;
Fu, Dehua ;
Liu, Shuang ;
Yao, Yang ;
Gao, Chun .
JOURNAL OF IMMUNOLOGY RESEARCH, 2019, 2019
[23]   L744,832 and Everolimus Induce Cytotoxic and Cytostatic Effects in Non-Hodgkin Lymphoma Cells [J].
Mendes, Jose ;
Goncalves, Ana Cristina ;
Alves, Raquel ;
Jorge, Joana ;
Pires, Ana ;
Ribeiro, Ana ;
Sarmento-Ribeiro, Ana Bela .
PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (02) :301-309
[24]   Antitumor effects of Endostar on non-Hodgkin's lymphoma by regulating endothelial progenitor cells through protein kinase B-dependent pathway [J].
Yu, Dandan ;
Wu, Hongge ;
Yang, Bohan ;
Yang, Kunyu ;
Liu, Hongli ;
Wu, Gang .
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2013, 45 (09) :742-748
[25]   Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studies [J].
Epstein, Mara M. ;
Rosner, Bernard ;
Breen, Elizabeth C. ;
Batista, Julie L. ;
Giovannucci, Edward L. ;
Magpantay, Larry ;
Aster, Jon C. ;
Rodig, Scott J. ;
Bertrand, Kimberly A. ;
Laden, Francine ;
Martinez-Maza, Otoniel ;
Birmann, Brenda M. .
HAEMATOLOGICA, 2018, 103 (10) :1679-1687
[26]   Expression of heat-shock protein-90 in non-Hodgkin's lymphomas [J].
Valbuena, JR ;
Rassidakis, GZ ;
Lin, P ;
Atwell, C ;
Georgakis, GV ;
Younes, A ;
Jones, D ;
Medeiros, LJ .
MODERN PATHOLOGY, 2005, 18 (10) :1343-1349
[27]   The Correlation Between Non-Hodgkin Lymphoma and Expression Levels of B-Cell Activating Factor and Its Receptors [J].
Shen, Xianjuan ;
Wang, Mei ;
Guo, Yuehua ;
Ju, Shaoqing .
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 25 (05) :837-844
[28]   Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma [J].
Chiang, Chun-Te ;
Yeh, Pei-Yen ;
Gao, Ming ;
Chen, Chun-Wei ;
Yeh, Ling-Chun ;
Feng, Wen-Chi ;
Kuo, Sung-Hsin ;
Hsu, Chih-Hung ;
Lu, Yen-Shen ;
Cheng, Ann-Lii .
CANCER LETTERS, 2010, 298 (02) :195-203
[29]   Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells [J].
Jacquemin, Guillaume ;
Granci, Virginie ;
Gallouet, Anne Sophie ;
Lalaoui, Najoua ;
Morle, Aymeric ;
Iessi, Elisabetta ;
Morizot, Alexandre ;
Garrido, Carmen ;
Guillaudeux, Thierry ;
Micheau, Olivier .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (01) :38-46
[30]   Serum BLyS levels increase after rituximab as initial therapy in patients with follicular grade 1 non-Hodgkin lymphoma [J].
Ansell, Stephen M. ;
Novak, Anne J. ;
Ziesmer, Steven ;
Price-Troska, Tammy ;
LaPlant, Betsy ;
Dillon, Stacey R. ;
Witzig, Thomas E. .
AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (02) :71-73